RECURSION PHARMACEUTICALS, INC.
Ticker: 1601830
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 18.55+141.9% | 7.67+18.5% | 6.47+24.9% | 5.18-73.0% | 19.22+30.3% | 14.75-43.4% | 26.08+80.9% | 14.42 |
| Total Income | 18.55+141.9% | 7.67+18.5% | 6.47+24.9% | 5.18-73.0% | 19.22+30.3% | 14.75-43.4% | 26.08+80.9% | 14.42 |
| EXPENSES | ||||||||
| Expenditure | 141.73-0.6% | 142.64+5.7% | 134.98-23.9% | 177.38-9.2% | 195.45-5.2% | 206.11+65.6% | 124.44+8.2% | 114.96 |
| Tax | 0.03 | 0.00+100.0% | -4.60 | 0.00 | 0.00+100.0% | -0.16-194.1% | 0.17+132.7% | -0.52 |
| PROFIT | ||||||||
| PBT | -119.01+9.2% | -131.01-7.3% | -122.11+24.7% | -162.25+5.6% | -171.90+15.2% | -202.65-111.8% | -95.68+2.4% | -98.06 |
| Net Profit | -119.04+9.1% | -131.01-11.5% | -117.50+27.6% | -162.25+5.6% | -171.90+15.1% | -202.49-111.3% | -95.84+1.7% | -97.54 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.22+12.0% | -0.25-13.6% | -0.22+38.9% | -0.36+12.2% | -0.41+18.0% | -0.50-47.1% | -0.34+15.0% | -0.40 |
Corporate Events
Board MeetingRXRX
202631Oct
Board Meeting
Fred Hassan appointed as Chair of the Board, increasing the …
SEC Filing ↗ Board MeetingRXRX
20265Aug
Board Meeting
Recursion Pharmaceuticals to report second quarter 2026 fina…
SEC Filing ↗ Board MeetingRXRX
202617Jun
Board Meeting
2026 Annual Meeting of Stockholders voting results for direc…
SEC Filing ↗ Board MeetingRXRX
202628Apr
Board Meeting
Director Departure — Christopher Gibson, Ph.D. will not stan…
SEC Filing ↗